Bringing Cohorts in Cahoots with Lab Science
The fields of epidemiology and toxicology sometimes find themselves at odds, but Gradient’s Julie Goodman, an epidemiologist and toxicologist, shares how the two disciplines can complement each other to evaluate public health risks. Dr. Goodman also dives into the finer points of systemic reviews and meta-analyses in her conversation with co-hosts Anne Chappelle and David Faulkner.
About the Guest
Julie E. Goodman, PhD, DABT, FACE, ATS, is an epidemiologist and board-certified toxicologist with over 20 years of experience. She is a Principal with Gradient and applies her multidisciplinary expertise to evaluate human health risks associated with chemical exposures in a variety of contexts, including products, foods, and medical applications, as well occupational and environmental exposures.
Dr. Goodman is a fellow of both the American College of Epidemiology and the Academy of Toxicological Sciences. She was also an adjunct faculty member in the Department of Epidemiology at the Harvard T. H. Chan School of Public Health, where she taught a class on meta-analysis for several years. Before joining Gradient, she was a Cancer Prevention Fellow at the National Cancer Institute.
Dr. Goodman has authored numerous original peer-reviewed research articles, review articles (including systematic reviews, meta-analyses, and weight-of-evidence evaluations), and book chapters on a wide variety of chemicals and health outcomes. She has presented her work to a wide variety of audiences.
Dr. Goodman obtained her master's in epidemiology and PhD in toxicology from Johns Hopkins University.
